Exact Mass: 461.2889564
Exact Mass Matches: 461.2889564
Found 500 metabolites which its exact mass value is equals to given mass value 461.2889564
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Galactosylsphingosine
Galactosylsphingosine (also known as psychosine), is an intermediate in the biosynthesis of cerebrosides. It is formed from the reaction of sphingosine with UDP-galactose and then reacts with fatty acid-coenzyme A to form the cerebroside. It is a galactoside metabolite of sphingosine and can function as a neurotoxin and a metabotoxin. A neurotoxin is a compound that disrupts or attacks neural cells and neural tissue. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Chronically high levels of galactosylsphingosine are associated with globoid cell leukodystrophy (Krabbe disease), which is characterized by the dysfunction of galactosylceramidase. Galactosylsphingosine is a highly cytotoxic lipid capable of inducing cell death in a wide variety of cell types including oligodendrocytes. It is known to accumulate in the nervous system in the absence of galactosylceramidase. Galactosylsphingosine localizes to lipid rafts and perturbs membrane integrity. It also inhibits protein kinase C translocation to the plasma membrane (PMID: 24006512). Symptoms of Krabbe disease begin between the ages of 3 and 6 months with irritability, fevers, limb stiffness, seizures, feeding difficulties, vomiting, and slowing of mental and motor development. In the first stages of the disease, the symptoms are often mistaken with those of cerebral palsy. Other symptoms include muscle weakness, spasticity, deafness, optic atrophy, optic nerve enlargement, blindness, paralysis, and difficulty when swallowing. An intermediate in the biosynthesis of cerebrosides. It is formed by reaction of sphingosine with UDP-galactose and then itself reacts with fatty acid-Coenzyme A to form the cerebroside. [HMDB] KEIO_ID P067; [MS2] KO009195 KEIO_ID P067
Glucosylsphingosine
Glucosylsphingosine is a cytotoxic compound. Accumulation of glucosylsphingosine in brain and other tisues occurs in patients with Gaucher disease, which is an inherited deficiency of lysosomal glucocerebrosidase. Glucocerebrosidase converts glucosylsphingosine to glucose and sphingosine. [HMDB] Glucosylsphingosine is a cytotoxic compound. Accumulation of glucosylsphingosine in brain and other tisues occurs in patients with Gaucher disease, which is an inherited deficiency of lysosomal glucocerebrosidase. Glucocerebrosidase converts glucosylsphingosine to glucose and sphingosine. Glucosylsphingosine (lyso-Gb1) is a deacylated form of glucosylceramide and is also degraded by the glucocerebrosidase. Glucosylsphingosine is a very promising, reliable and specific biomarker for monitoring Gaucher disease[1].
(5Z,8Z,10E,14Z,17Z)-12-Hydroxyicosa-5,8,10,14,17-pentaenoylcarnitine
C27H43NO5 (461.31410680000005)
(5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoylcarnitine is an acylcarnitine. More specifically, it is an (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(2R,3R,4S,5R,6R)-2-[(E)-2-Amino-3-hydroxy-octadec-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
Z-Leu-Leu-Norvalinal
Verdamicin
2,5-Piperazinedione, 3-[[2-(1,1-dimethyl-2-propenyl)-5,7-bis(3-methyl-2-butenyl)-1H-indol-3-yl]methyl]-6-methyl-, (3S,6S)-
Psychosine
A glycosylsphingoid consisting of sphingosine having a beta-D-galactosyl residue attached at the 1-position.
(-)-10-demethyltubulosine|10-demethyltubulosine|9-desmethyltubulosine|demethyltubulosine
(2R,4bR,6aS,12bS,12cS,14aS)-4b-deoxy-1-O-acetylpaxilline
C29H35NO4 (461.25659500000006)
4alpha,7alpha-oxa-5,6-dihydro-14alpha-hydroxyveramarine|neogermine
C27H43NO5 (461.31410680000005)
N-(4-methyl-2-oxochromen-7-yl)icosa-5,8,11,14-tetraenamide
C30H39NO3 (461.29297840000004)
Ser Lys Val Glu
Thr Val Asp Lys
Val Glu Ser Lys
echinulin
An indole alkaloid with formula C29H39N3O2. It is a fungal metabolite found in several Aspergillus species.
Ala Cys Ile Arg
C18H35N7O5S (461.24202600000007)
Ala Cys Leu Arg
C18H35N7O5S (461.24202600000007)
Ala Cys Arg Ile
C18H35N7O5S (461.24202600000007)
Ala Cys Arg Leu
C18H35N7O5S (461.24202600000007)
Ala Phe Lys Pro
C23H35N5O5 (461.26380600000005)
Ala Phe Pro Lys
C23H35N5O5 (461.26380600000005)
Ala Ile Cys Arg
C18H35N7O5S (461.24202600000007)
Ala Ile Lys Met
C20H39N5O5S (461.26717640000004)
Ala Ile Met Lys
C20H39N5O5S (461.26717640000004)
Ala Ile Arg Cys
C18H35N7O5S (461.24202600000007)
Ala Lys Phe Pro
C23H35N5O5 (461.26380600000005)
Ala Lys Ile Met
C20H39N5O5S (461.26717640000004)
Ala Lys Leu Met
C20H39N5O5S (461.26717640000004)
Ala Lys Met Ile
C20H39N5O5S (461.26717640000004)
Ala Lys Met Leu
C20H39N5O5S (461.26717640000004)
Ala Lys Pro Phe
C23H35N5O5 (461.26380600000005)
Ala Leu Cys Arg
C18H35N7O5S (461.24202600000007)
Ala Leu Lys Met
C20H39N5O5S (461.26717640000004)
Ala Leu Met Lys
C20H39N5O5S (461.26717640000004)
Ala Leu Arg Cys
C18H35N7O5S (461.24202600000007)
Ala Met Ile Lys
C20H39N5O5S (461.26717640000004)
Ala Met Lys Ile
C20H39N5O5S (461.26717640000004)
Ala Met Lys Leu
C20H39N5O5S (461.26717640000004)
Ala Met Leu Lys
C20H39N5O5S (461.26717640000004)
Ala Pro Phe Lys
C23H35N5O5 (461.26380600000005)
Ala Pro Lys Phe
C23H35N5O5 (461.26380600000005)
Ala Arg Cys Ile
C18H35N7O5S (461.24202600000007)
Ala Arg Cys Leu
C18H35N7O5S (461.24202600000007)
Ala Arg Ile Cys
C18H35N7O5S (461.24202600000007)
Ala Arg Leu Cys
C18H35N7O5S (461.24202600000007)
Cys Ala Ile Arg
C18H35N7O5S (461.24202600000007)
Cys Ala Leu Arg
C18H35N7O5S (461.24202600000007)
Cys Ala Arg Ile
C18H35N7O5S (461.24202600000007)
Cys Ala Arg Leu
C18H35N7O5S (461.24202600000007)
Cys Ile Ala Arg
C18H35N7O5S (461.24202600000007)
Cys Ile Lys Val
C20H39N5O5S (461.26717640000004)
Cys Ile Arg Ala
C18H35N7O5S (461.24202600000007)
Cys Ile Val Lys
C20H39N5O5S (461.26717640000004)
Cys Lys Ile Val
C20H39N5O5S (461.26717640000004)
Cys Lys Leu Val
C20H39N5O5S (461.26717640000004)
Cys Lys Val Ile
C20H39N5O5S (461.26717640000004)
Cys Lys Val Leu
C20H39N5O5S (461.26717640000004)
Cys Leu Ala Arg
C18H35N7O5S (461.24202600000007)
Cys Leu Lys Val
C20H39N5O5S (461.26717640000004)
Cys Leu Arg Ala
C18H35N7O5S (461.24202600000007)
Cys Leu Val Lys
C20H39N5O5S (461.26717640000004)
Cys Arg Ala Ile
C18H35N7O5S (461.24202600000007)
Cys Arg Ala Leu
C18H35N7O5S (461.24202600000007)
Cys Arg Ile Ala
C18H35N7O5S (461.24202600000007)
Cys Arg Leu Ala
C18H35N7O5S (461.24202600000007)
Cys Val Ile Lys
C20H39N5O5S (461.26717640000004)
Cys Val Lys Ile
C20H39N5O5S (461.26717640000004)
Cys Val Lys Leu
C20H39N5O5S (461.26717640000004)
Cys Val Leu Lys
C20H39N5O5S (461.26717640000004)
Asp Ile Lys Ser
Asp Ile Ser Lys
Asp Lys Ile Ser
Asp Lys Leu Ser
Asp Lys Ser Ile
Asp Lys Ser Leu
Asp Lys Thr Val
Asp Lys Val Thr
Asp Leu Lys Ser
Asp Leu Ser Lys
Asp Ser Ile Lys
Asp Ser Lys Ile
Asp Ser Lys Leu
Asp Ser Leu Lys
Asp Thr Lys Val
Asp Thr Val Lys
Asp Val Lys Thr
Asp Val Thr Lys
Glu Lys Ser Val
Glu Lys Val Ser
Glu Ser Lys Val
Glu Ser Val Lys
Glu Val Lys Ser
Glu Val Ser Lys
Phe Ala Lys Pro
C23H35N5O5 (461.26380600000005)
Phe Ala Pro Lys
C23H35N5O5 (461.26380600000005)
Phe Lys Ala Pro
C23H35N5O5 (461.26380600000005)
Phe Lys Pro Ala
C23H35N5O5 (461.26380600000005)
Phe Pro Ala Lys
C23H35N5O5 (461.26380600000005)
Phe Pro Lys Ala
C23H35N5O5 (461.26380600000005)
Gly Met Arg Val
C18H35N7O5S (461.24202600000007)
Gly Met Val Arg
C18H35N7O5S (461.24202600000007)
Gly Arg Met Val
C18H35N7O5S (461.24202600000007)
Gly Arg Val Met
C18H35N7O5S (461.24202600000007)
Gly Val Met Arg
C18H35N7O5S (461.24202600000007)
Gly Val Arg Met
C18H35N7O5S (461.24202600000007)
Ile Ala Cys Arg
C18H35N7O5S (461.24202600000007)
Ile Ala Lys Met
C20H39N5O5S (461.26717640000004)
Ile Ala Met Lys
C20H39N5O5S (461.26717640000004)
Ile Ala Arg Cys
C18H35N7O5S (461.24202600000007)
Ile Cys Ala Arg
C18H35N7O5S (461.24202600000007)
Ile Cys Lys Val
C20H39N5O5S (461.26717640000004)
Ile Cys Arg Ala
C18H35N7O5S (461.24202600000007)
Ile Cys Val Lys
C20H39N5O5S (461.26717640000004)
Ile Asp Lys Ser
Ile Asp Ser Lys
Ile Lys Ala Met
C20H39N5O5S (461.26717640000004)
Ile Lys Cys Val
C20H39N5O5S (461.26717640000004)
Ile Lys Asp Ser
Ile Lys Met Ala
C20H39N5O5S (461.26717640000004)
Ile Lys Ser Asp
Ile Lys Thr Thr
Ile Lys Val Cys
C20H39N5O5S (461.26717640000004)
Ile Met Ala Lys
C20H39N5O5S (461.26717640000004)
Ile Met Lys Ala
C20H39N5O5S (461.26717640000004)
Ile Gln Thr Thr
Ile Arg Ala Cys
C18H35N7O5S (461.24202600000007)
Ile Arg Cys Ala
C18H35N7O5S (461.24202600000007)
Ile Arg Ser Ser
Ile Ser Asp Lys
Ile Ser Lys Asp
Ile Ser Arg Ser
Ile Ser Ser Arg
Ile Thr Lys Thr
Ile Thr Gln Thr
Ile Thr Thr Lys
Ile Thr Thr Gln
Ile Val Cys Lys
C20H39N5O5S (461.26717640000004)
Ile Val Lys Cys
C20H39N5O5S (461.26717640000004)
Lys Ala Phe Pro
C23H35N5O5 (461.26380600000005)
Lys Ala Ile Met
C20H39N5O5S (461.26717640000004)
Lys Ala Leu Met
C20H39N5O5S (461.26717640000004)
Lys Ala Met Ile
C20H39N5O5S (461.26717640000004)
Lys Ala Met Leu
C20H39N5O5S (461.26717640000004)
Lys Ala Pro Phe
C23H35N5O5 (461.26380600000005)
Lys Cys Ile Val
C20H39N5O5S (461.26717640000004)
Lys Cys Leu Val
C20H39N5O5S (461.26717640000004)
Lys Cys Val Ile
C20H39N5O5S (461.26717640000004)
Lys Cys Val Leu
C20H39N5O5S (461.26717640000004)
Lys Asp Ile Ser
Lys Asp Leu Ser
Lys Asp Ser Ile
Lys Asp Ser Leu
Lys Asp Thr Val
Lys Asp Val Thr
Lys Glu Ser Val
Lys Glu Val Ser
Lys Phe Ala Pro
C23H35N5O5 (461.26380600000005)
Lys Phe Pro Ala
C23H35N5O5 (461.26380600000005)
Lys Ile Ala Met
C20H39N5O5S (461.26717640000004)
Lys Ile Cys Val
C20H39N5O5S (461.26717640000004)
Lys Ile Asp Ser
Lys Ile Met Ala
C20H39N5O5S (461.26717640000004)
Lys Ile Ser Asp
Lys Ile Thr Thr
Lys Ile Val Cys
C20H39N5O5S (461.26717640000004)
Lys Leu Ala Met
C20H39N5O5S (461.26717640000004)
Lys Leu Cys Val
C20H39N5O5S (461.26717640000004)
Lys Leu Asp Ser
Lys Leu Met Ala
C20H39N5O5S (461.26717640000004)
Lys Leu Ser Asp
Lys Leu Thr Thr
Lys Leu Val Cys
C20H39N5O5S (461.26717640000004)
Lys Met Ala Ile
C20H39N5O5S (461.26717640000004)
Lys Met Ala Leu
C20H39N5O5S (461.26717640000004)
Lys Met Ile Ala
C20H39N5O5S (461.26717640000004)
Lys Met Leu Ala
C20H39N5O5S (461.26717640000004)
Lys Pro Ala Phe
C23H35N5O5 (461.26380600000005)
Lys Pro Phe Ala
C23H35N5O5 (461.26380600000005)
Lys Ser Asp Ile
Lys Ser Asp Leu
Lys Ser Glu Val
Lys Ser Ile Asp
Lys Ser Leu Asp
Lys Ser Val Glu
Lys Thr Asp Val
Lys Thr Ile Thr
Lys Thr Leu Thr
Lys Thr Thr Ile
Lys Thr Thr Leu
Lys Thr Val Asp
Lys Val Cys Ile
C20H39N5O5S (461.26717640000004)
Lys Val Cys Leu
C20H39N5O5S (461.26717640000004)
Lys Val Asp Thr
Lys Val Glu Ser
Lys Val Ile Cys
C20H39N5O5S (461.26717640000004)
Lys Val Leu Cys
C20H39N5O5S (461.26717640000004)
Lys Val Ser Glu
Lys Val Thr Asp
Leu Ala Cys Arg
C18H35N7O5S (461.24202600000007)
Leu Ala Lys Met
C20H39N5O5S (461.26717640000004)
Leu Ala Met Lys
C20H39N5O5S (461.26717640000004)
Leu Ala Arg Cys
C18H35N7O5S (461.24202600000007)
Leu Cys Ala Arg
C18H35N7O5S (461.24202600000007)
Leu Cys Lys Val
C20H39N5O5S (461.26717640000004)
Leu Cys Arg Ala
C18H35N7O5S (461.24202600000007)
Leu Cys Val Lys
C20H39N5O5S (461.26717640000004)
Leu Asp Lys Ser
Leu Asp Ser Lys
Leu Lys Ala Met
C20H39N5O5S (461.26717640000004)
Leu Lys Cys Val
C20H39N5O5S (461.26717640000004)
Leu Lys Asp Ser
Leu Lys Met Ala
C20H39N5O5S (461.26717640000004)
Leu Lys Ser Asp
Leu Lys Thr Thr
Leu Lys Val Cys
C20H39N5O5S (461.26717640000004)
Leu Met Ala Lys
C20H39N5O5S (461.26717640000004)
Leu Met Lys Ala
C20H39N5O5S (461.26717640000004)
Leu Gln Thr Thr
Leu Arg Ala Cys
C18H35N7O5S (461.24202600000007)
Leu Arg Cys Ala
C18H35N7O5S (461.24202600000007)
Leu Arg Ser Ser
Leu Ser Asp Lys
Leu Ser Lys Asp
Leu Ser Arg Ser
Leu Ser Ser Arg
Leu Thr Lys Thr
Leu Thr Gln Thr
Leu Thr Thr Lys
Leu Thr Thr Gln
Leu Val Cys Lys
C20H39N5O5S (461.26717640000004)
Leu Val Lys Cys
C20H39N5O5S (461.26717640000004)
Met Ala Ile Lys
C20H39N5O5S (461.26717640000004)
Met Ala Lys Ile
C20H39N5O5S (461.26717640000004)
Met Ala Lys Leu
C20H39N5O5S (461.26717640000004)
Met Ala Leu Lys
C20H39N5O5S (461.26717640000004)
Met Gly Arg Val
C18H35N7O5S (461.24202600000007)
Met Gly Val Arg
C18H35N7O5S (461.24202600000007)
Met Ile Ala Lys
C20H39N5O5S (461.26717640000004)
Met Ile Lys Ala
C20H39N5O5S (461.26717640000004)
Met Lys Ala Ile
C20H39N5O5S (461.26717640000004)
Met Lys Ala Leu
C20H39N5O5S (461.26717640000004)
Met Lys Ile Ala
C20H39N5O5S (461.26717640000004)
Met Lys Leu Ala
C20H39N5O5S (461.26717640000004)
Met Leu Ala Lys
C20H39N5O5S (461.26717640000004)
Met Leu Lys Ala
C20H39N5O5S (461.26717640000004)
Met Arg Gly Val
C18H35N7O5S (461.24202600000007)
Met Arg Val Gly
C18H35N7O5S (461.24202600000007)
Met Val Gly Arg
C18H35N7O5S (461.24202600000007)
Met Val Arg Gly
C18H35N7O5S (461.24202600000007)
Pro Ala Phe Lys
C23H35N5O5 (461.26380600000005)
Pro Ala Lys Phe
C23H35N5O5 (461.26380600000005)
Pro Phe Ala Lys
C23H35N5O5 (461.26380600000005)
Pro Phe Lys Ala
C23H35N5O5 (461.26380600000005)
Pro Lys Ala Phe
C23H35N5O5 (461.26380600000005)
Pro Lys Phe Ala
C23H35N5O5 (461.26380600000005)
Gln Ile Thr Thr
Gln Leu Thr Thr
Gln Thr Ile Thr
Gln Thr Leu Thr
Gln Thr Thr Ile
Gln Thr Thr Leu
Arg Ala Cys Ile
C18H35N7O5S (461.24202600000007)
Arg Ala Cys Leu
C18H35N7O5S (461.24202600000007)
Arg Ala Ile Cys
C18H35N7O5S (461.24202600000007)
Arg Ala Leu Cys
C18H35N7O5S (461.24202600000007)
Arg Cys Ala Ile
C18H35N7O5S (461.24202600000007)
Arg Cys Ala Leu
C18H35N7O5S (461.24202600000007)
Arg Cys Ile Ala
C18H35N7O5S (461.24202600000007)
Arg Cys Leu Ala
C18H35N7O5S (461.24202600000007)
Arg Gly Met Val
C18H35N7O5S (461.24202600000007)
Arg Gly Val Met
C18H35N7O5S (461.24202600000007)
Arg Ile Ser Ser
Arg Leu Ser Ser
Arg Ser Ile Ser
Arg Ser Leu Ser
Arg Ser Ser Ile
Arg Ser Ser Leu
Arg Ser Thr Val
Arg Ser Val Thr
Arg Thr Ser Val
Arg Thr Val Ser
Arg Val Ser Thr
Arg Val Thr Ser
Ser Asp Ile Lys
Ser Asp Lys Ile
Ser Asp Lys Leu
Ser Asp Leu Lys
Ser Glu Lys Val
Ser Glu Val Lys
Ser Ile Asp Lys
Ser Ile Lys Asp
Ser Ile Arg Ser
Ser Ile Ser Arg
Ser Lys Asp Ile
Ser Lys Asp Leu
Ser Lys Glu Val
Ser Lys Ile Asp
Ser Lys Leu Asp
Ser Leu Asp Lys
Ser Leu Lys Asp
Ser Leu Arg Ser
Ser Leu Ser Arg
Ser Arg Ile Ser
Ser Arg Leu Ser
Ser Arg Ser Ile
Ser Arg Ser Leu
Ser Arg Thr Val
Ser Arg Val Thr
Ser Ser Ile Arg
Ser Ser Leu Arg
Ser Ser Arg Ile
Ser Ser Arg Leu
Ser Thr Arg Val
Ser Thr Val Arg
Ser Val Glu Lys
Ser Val Lys Glu
Ser Val Arg Thr
Ser Val Thr Arg
Thr Asp Lys Val
Thr Asp Val Lys
Thr Ile Lys Thr
Thr Ile Gln Thr
Thr Ile Thr Lys
Thr Ile Thr Gln
Thr Lys Asp Val
Thr Lys Ile Thr
Thr Lys Leu Thr
Thr Lys Thr Ile
Thr Lys Thr Leu
Thr Lys Val Asp
Thr Leu Lys Thr
Thr Leu Gln Thr
Thr Leu Thr Lys
Thr Leu Thr Gln
Thr Gln Ile Thr
Thr Gln Leu Thr
Thr Gln Thr Ile
Thr Gln Thr Leu
Thr Arg Ser Val
Thr Arg Val Ser
Thr Ser Arg Val
Thr Ser Val Arg
Thr Thr Ile Lys
Thr Thr Ile Gln
Thr Thr Lys Ile
Thr Thr Lys Leu
Thr Thr Leu Lys
Thr Thr Leu Gln
Thr Thr Gln Ile
Thr Thr Gln Leu
Thr Val Lys Asp
Thr Val Arg Ser
Thr Val Ser Arg
Val Cys Ile Lys
C20H39N5O5S (461.26717640000004)
Val Cys Lys Ile
C20H39N5O5S (461.26717640000004)
Val Cys Lys Leu
C20H39N5O5S (461.26717640000004)
Val Cys Leu Lys
C20H39N5O5S (461.26717640000004)
Val Asp Lys Thr
Val Asp Thr Lys
Val Glu Lys Ser
Val Ile Cys Lys
C20H39N5O5S (461.26717640000004)
Val Ile Lys Cys
C20H39N5O5S (461.26717640000004)
Val Lys Cys Ile
C20H39N5O5S (461.26717640000004)
Val Lys Cys Leu
C20H39N5O5S (461.26717640000004)
Val Lys Asp Thr
Val Lys Glu Ser
Val Lys Ile Cys
C20H39N5O5S (461.26717640000004)
Val Lys Leu Cys
C20H39N5O5S (461.26717640000004)
Val Lys Ser Glu
Val Lys Thr Asp
Val Leu Cys Lys
C20H39N5O5S (461.26717640000004)
Val Leu Lys Cys
C20H39N5O5S (461.26717640000004)
Val Arg Ser Thr
Val Arg Thr Ser
Val Ser Glu Lys
Val Ser Lys Glu
Val Ser Arg Thr
Val Ser Thr Arg
Val Thr Asp Lys
Val Thr Lys Asp
Val Thr Arg Ser
Val Thr Ser Arg
serinol amide
AMC Arachidonoyl Amide
C30H39NO3 (461.29297840000004)
1-[[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]methyl]cyclopentane-1-carboxylic acid
5(S)-[1(S)-Azido-3(S)-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3(S)-isopropyldihydrofuran-2-one
Methylbenzethonium chloride
C28H44ClNO2 (461.30603940000003)
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents
OCTYLCRESOXYETHOXYETHYL DIMETHYL-BENZYL AMMONIUM CHLORIDE
C28H44ClNO2 (461.30603940000003)
MG-115
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D007976 - Leupeptins
Edicotinib
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
(3S,10R,13R)-3-[[4-(2-hydroxyethoxy)phenyl]methyl]-4,10-dimethyl-13-pentyl-1-oxa-4-azacyclotridecane-2,5-dione
C27H43NO5 (461.31410680000005)
5,8,11,14-Eicosatetraenamide, N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, (5Z,8Z,11Z,14Z)-
C30H39NO3 (461.29297840000004)
(R)-oleoylcarnitine hydrochloride
C25H48ClNO4 (461.32716780000004)
A quaternary ammonium salt obtained by combining (R)-oleoylcarnitine with one molar equivalent of hydrogen chloride.
(2S)-N-[(S)-[(2S,4R,6R)-6-[(2S)-2,3-dihydroxypropyl]-4-hydroxy-5,5-dimethyloxan-2-yl]-hydroxymethyl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide
(5Z,8Z,10E,14Z,17Z)-12-Hydroxyicosa-5,8,10,14,17-pentaenoylcarnitine
C27H43NO5 (461.31410680000005)
4-[(6,7-diethoxy-2,4-dioxo-1H-quinazolin-3-yl)methyl]-N-(3-methoxypropyl)-1-cyclohexanecarboxamide
C24H35N3O6 (461.25257300000004)
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyrrolidin-1-ylethyl)acetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyrrolidin-1-ylethyl)acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(2-pyrrolidin-1-ylethyl)acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
(8S,9R,10R)-9-[4-(1-cyclopentenyl)phenyl]-10-(hydroxymethyl)-N-(4-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C24H35N3O6 (461.25257300000004)
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
(8R,9S,10S)-9-[4-(1-cyclopentenyl)phenyl]-10-(hydroxymethyl)-N-(4-methoxyphenyl)-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
[(4R)-4-[[(2S)-1-[(2R)-2-acetamido-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-4-boronobutyl]-(diaminomethylidene)azanium
(2S,3S,3aR,9bR)-2-(4-benzylpiperidine-1-carbonyl)-3-(hydroxymethyl)-1-methyl-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(2R,3R,3aS,9bS)-2-(4-benzylpiperidine-1-carbonyl)-3-(hydroxymethyl)-1-methyl-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
2-aminoethyl [2-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propyl] hydrogen phosphate
C23H44NO6P (461.29060940000005)
(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]dec-4-ene-1-sulfonic acid
C23H43NO6S (461.28109380000006)
(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]undec-4-ene-1-sulfonic acid
C23H43NO6S (461.28109380000006)
(E)-3-hydroxy-2-(tridecanoylamino)undec-4-ene-1-sulfonic acid
C24H47NO5S (461.31747720000004)
(E)-3-hydroxy-2-(undecanoylamino)tridec-4-ene-1-sulfonic acid
C24H47NO5S (461.31747720000004)
3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]decane-1-sulfonic acid
C24H47NO5S (461.31747720000004)
(E)-3-hydroxy-2-(tetradecanoylamino)dec-4-ene-1-sulfonic acid
C24H47NO5S (461.31747720000004)
(E)-2-(dodecanoylamino)-3-hydroxydodec-4-ene-1-sulfonic acid
C24H47NO5S (461.31747720000004)
3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]undecane-1-sulfonic acid
C24H47NO5S (461.31747720000004)
(E)-2-(decanoylamino)-3-hydroxytetradec-4-ene-1-sulfonic acid
C24H47NO5S (461.31747720000004)
2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)tetradeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium
C22H42N2O6P+ (461.27803420000004)
2-[[(4E,8E,12E)-2-acetamido-3-hydroxypentadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C22H42N2O6P+ (461.27803420000004)
Glucosylsphingosine
Glucosylsphingosine (lyso-Gb1) is a deacylated form of glucosylceramide and is also degraded by the glucocerebrosidase. Glucosylsphingosine is a very promising, reliable and specific biomarker for monitoring Gaucher disease[1].
PF 1163B
C27H43NO5 (461.31410680000005)
A macrolide antibiotic that is 4,10-dimethyl-1-oxa-4-azacyclotridecane-2,5-dione substituted by a 4-(2-hydroxyethoxy)benzyl group at position 3 and a pentyl group at position 13 (the 3S,10R,13S stereoisomer). It is isolated from Penicillium sp.PF1163 and exhibits antifungal activity against the pathogenic fungal strain Candida albicans TIMM1768.
Hex1SPH(18:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(3s,4r,7r,9s,10s,13s,14s,16r,19s,27s)-17,19-dihydroxy-7-methyl-13-[(1z)-prop-1-en-1-yl]-2-oxa-18-azahexacyclo[19.2.2.1³,¹⁰.1¹⁶,¹⁹.0⁴,⁹.0¹⁴,²⁷]heptacosa-1(23),11,17,21,24-pentaen-15-one
C29H35NO4 (461.25659500000006)
(3s,6s)-3-{[5,7-bis(3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol
3-{[4-(2-hydroxyethoxy)phenyl]methyl}-4,10-dimethyl-13-pentyl-1-oxa-4-azacyclotridecane-2,5-dione
C27H43NO5 (461.31410680000005)
7,11,19-trimethyl-26-oxa-13-azaheptacyclo[21.2.1.0²,¹⁸.0³,¹⁶.0⁶,¹⁵.0⁸,¹³.0¹⁹,²⁴]hexacosane-3,5,7,22-tetrol
C27H43NO5 (461.31410680000005)
3-ethyl-2-({6-hydroxy-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}methyl)-10-methoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-9-ol
(2s,3as,6r,7as)-1-[(2s,3r)-2-{[(2r)-1,2-dihydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-methylpentanoyl]-6-hydroxy-octahydroindole-2-carboximidic acid
C24H35N3O6 (461.25257300000004)
(2r,3r,4r,5r)-2-{[(1s,2s,3r,4s,6r)-4,6-diamino-3-{[(2s,3r)-3-amino-6-[(methylamino)methyl]-3,4-dihydro-2h-pyran-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
17,19-dihydroxy-7-methyl-13-(prop-1-en-1-yl)-2-oxa-18-azahexacyclo[19.2.2.1³,¹⁰.1¹⁶,¹⁹.0⁴,⁹.0¹⁴,²⁷]heptacosa-1(23),11,17,21,24-pentaen-15-one
C29H35NO4 (461.25659500000006)